Now, the US Drug Enforcement Administration (DEA) classifies copyright as a Timetable II drug, recognizing its large likely for abuse but nevertheless permitting its restricted use for health-related needs. On the other hand, current pharmacoepidemiological trends suggest that copyright may soon reach The purpose wherever, in functional terms, it i